单克隆丙种球蛋白病与血清免疫球蛋白水平作为慢性淋巴细胞白血病的预后因素
该研究纳入1505例慢性淋巴细胞白血病(CLL)患者,依据诊断时免疫球蛋白(Ig)异常分为四组:IgM型单克隆丙种球蛋白病(IgM/CLL)73例(4.8%)、IgG型单克隆丙种球蛋白病(IgG/CLL)149例(10%)、低丙种球蛋白血症(hypo-γ)200例(13.2%)及免疫球蛋白水平正常(γ-normal)1083例(72%)。IgM副蛋白与更晚期的Binet/Rai分期及del(17p)/TP53突变显著相关,IgG异常与12三体发生率更高相关。任何类型Ig异常患者的无治疗生存期(TFS)均较Ig水平正常者缩短,但总生存期(OS)无显著影响。
要点
- IgM副蛋白与更晚期Binet/Rai分期及del(17p)/TP53突变显著相关。
- IgG异常与12三体发生率更高相关。
- 任何类型Ig异常患者TFS较短,但OS无显著影响。
核心结论
- CLL患者中IgM、IgG、低丙种球蛋白血症及正常Ig水平四组分布分别为73例(4.8%)、149例(10%)、200例(13.2%)和1083例(72%)。
研究设计与样本
- 研究纳入1505例CLL患者,依据诊断时免疫球蛋白异常分为四个亚组。
主要发现
- IgM副蛋白与更晚期Binet/Rai分期及del(17p)/TP53突变显著相关。
- IgG异常与12三体发生率更高相关。
- 任何类型Ig异常患者较Ig水平正常者TFS缩短,但OS无显著影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The relationship between chronic lymphocytic leukaemia (CLL) and qualitative/quantitative gammaglobulin abnormalities is well established. Nevertheless, in order to better understand this kind of connection, we examined 1505 patients with CLL and divided them into four subgroups on the basis of immunoglobulin (Ig) aberrations at diagnosis. A total of 73 (4·8%), 149 (10%), 200 (13·2%) and 1083 (72%) patients were identified with IgM monoclonal gammopathy (IgM/CLL), IgG monoclonal gammopathy (IgG/CLL), hypogammaglobulinaemia (hypo-γ) and normal Ig levels (γ-normal) respectively. IgM paraprotein was significantly associated with a more advanced Binet/Rai stage and del(17p)/TP53 mutation, while IgG abnormalities correlated with a higher occurrence of trisomy 12. Patients with any type of Ig abnormality had shorter treatment-free survival (TFS) but no significant impact affecting overall survival (OS) compared to those with normal Ig levels.
引用
- Corbingi A, Innocenti I, Tomasso A, et al. Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia. Br J Haematol. 2020. PMID: 32712965. doi:10.1111/bjh.16975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。